HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
DYN
Dyne Therapeutics Inc
Healthcare Biotechnology · Massachusetts, USA · Reports in usd
Market Cap: $2.59B
Market Cap
$2.59B
Enterprise Val
$1.65B
P/E Ratio
-5.81
P/B Ratio
2.67
Trailing PEG (1Y)
0.34
As Of
Apr 27, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$972.1M
Return on Equity-61.45%
Return on Assets-50.94%
Current Ratio22.25
Debt/Equity0.17
LT Debt/Equity0.17
Revenue Per Share0.00

Income Statement

Dec 31, 2025
Revenue$0.00
Cost of Revenue$0.00
Gross Profit$0.00
R&D$95.4M
SG&A$20.7M
Operating Expenses$116.1M
Operating Income-$116.1M
Interest Expense$3.2M
Tax Expense$0.00
Net Income-$112.0M
EPS (Basic)$-0.73
EPS (Diluted)$-0.73
EBIT-$108.8M
EBITDA-$108.2M
Consolidated Income-$112.0M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$893.4M
Accounts Receivable$0.00
Inventory$0.00
Current Assets$1.13B
LT Investments$0.00
Property, Plant & Equipment$44.8M
Intangibles$0.00
Non-Current Assets$60.4M
Total Assets$1.19B
Accounts Payable$8.1M
Current Debt$5.0M
Current Liabilities$50.6M
LT Debt$164.2M
Non-Current Liabilities$164.2M
Total Liabilities$214.8M
Total Debt$169.2M
Retained Earnings-$1.40B
Shareholder Equity$972.1M
Shares Outstanding142,824,687

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$111.8M
Investing Cash Flow$982.0K
Financing Cash Flow$431.0M
CapEx-$484.0K
Free Cash Flow-$112.3M
Depreciation & Amort.$556.0K
Stock-Based Comp$11.2M
Acquisitions / Disposals$0.00
Investment Activity$1.5M
Debt Issued/Repaid$49.4M
Equity Issued/Repaid$381.5M
Dividends Paid$0.00
Net Change in Cash$320.1M
Data cached · Meta live · Daily live · Statements live · TTL 24h